Search clinical trials for: Triple Artemisinin Combination Therapy

Total 65297 results

Allergan

Completed

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Mexico, Colombia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Children With Neuroblastoma

Neuroblastoma

United States, Canada, Australia, Switzerland, Puerto Rico, Netherlands, New Zealand
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

Brain Tumors | Central Nervous System Tumors

United States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma

Brain Tumors | Central Nervous System Tumors

United States, Canada, Netherlands, Puerto Rico, Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia

Leukemia

United States, Canada, Netherlands, Puerto Rico, Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma

Brain Tumors | Central Nervous System Tumors

United States, Canada, Netherlands, Puerto Rico, Switzerland
Adamas Pharmaceuticals, Inc.

Completed

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects (PO206)

Influenza

United States, Australia, Canada, Netherlands, Singapore
Centre Jean Perrin
Sanofi; Merck Sharp & Dohme LLC

Completed

Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.

Breast Cancer

France
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma

Sarcoma

United States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Sarcoma

United States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
Institute of Tropical Medicine, Belgium
University Hospital Tuebingen; Mbarara University of Science and Technology; Liverpool... and other collaborators

Completed

Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

Fever | Malaria

Burkina Faso, Gabon, Mozambique, Nigeria, Rwanda, Uganda, Zambia
London School of Hygiene and Tropical Medicine
Radboud University Medical Center; European Union; Kilimanjaro Christian Medical...

Completed

Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2) (TRANSACT2)

Malaria

Kenya
Sabah Ahmed Omar
Kenya Medical Research Institute; World Bank

Unknown

Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya (EAPHLNP)

Malaria

Kenya
dr. schwandner

Unknown

Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation (3T-CO)

Chronic Obstipation

Germany
Allergan

Completed

Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

India
Kilimanjaro Clinical Research Institute
London School of Hygiene and Tropical Medicine; Ifakara Health Institute

Unknown

The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy

Malaria Transmission

Tanzania
Allergan

Withdrawn

Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma
Janssen-Cilag S.p.A.

Completed

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients (MONARCH)

Human Immunodeficiency Virus 1
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer

Lung Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma

Lymphoma

United States
Kintampo Health Research Centre, Ghana
London School of Hygiene and Tropical Medicine

Completed

Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial (RDT-ACT)

Malaria

Ghana
Janssen-Cilag International NV

Completed

Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir (MONET)

HIV Infections | Human Immunodeficiency Virus | Acquired Immunodeficiency Syndrome Virus | AIDS Virus

United Kingdom, Belgium, Germany, Spain, Portugal, Israel, Denmark, Russian Federation, Austria, Hungary, Switzerland
DBL -Institute for Health Research and Development
London School of Hygiene and Tropical Medicine; Ministry of Health, Uganda; Artemisinin-based...

Completed

Introducing Rapid Diagnostic Tests Into the Private Health Sector

Fever | Malaria | Diagnosis | Referral

Uganda
DBL -Institute for Health Research and Development
London School of Hygiene and Tropical Medicine; Ministry of Health, Uganda; Artemisinin-based...

Completed

Role and Effectiveness of Rapid Diagnostic Tests in Home-based Management of Malaria (ACTUGA2)

Fever | Malaria

Uganda
Centers for Disease Control and Prevention
United States Agency for International Development (USAID)

Completed

Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria

Malaria (Uncomplicated)

Tanzania
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Lung Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer

Lung Cancer

United States, Canada
Takeda

Completed

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Centers for Disease Control and Prevention

Completed

Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children

P. Falciparum Malaria

Tanzania
Navrongo Health Research Centre, Ghana
DBL -Institute for Health Research and Development

Unknown

Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana (ACTIPT)

Anemia | Malaria | Helminthiasis | Schistosomiasis | Change in Sustained Attention

Ghana
Fudan University

Completed

Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC

Metastatic Breast Cancer

China
London School of Hygiene and Tropical Medicine
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; Ifakara Health Institute

Unknown

IMPACT2: Monitoring Interventions to Improve Artemisinin-based Combination Therapy (ACT) Access and Targeting (IMPACT2)

Malaria | Anaemia

Tanzania
sigma-tau i.f.r. S.p.A.
Medicines for Malaria Venture

Completed

Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers

Malaria, Falciparum

France
Novartis

Terminated

Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome (ALTO)

Hypertension With Metabolic Syndrome

United Kingdom
Bristol-Myers Squibb

Completed

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

HIV Infections

United States
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Pyronaridine/Artesunate -Ritonavir Drug Drug Interaction Study

Malaria

Switzerland
Samsung Medical Center

Completed

Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME)

Diabetic Retinopathy | Macular Edema

Korea, Republic of
Radboud University Medical Center
European Union; Kilimanjaro Christian Medical Centre, Tanzania

Completed

Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT) (TRANSACT)

Uncomplicated Malaria

Kenya, Tanzania
London School of Hygiene and Tropical Medicine
HealthNet TPO

Completed

Trial of Artesunate Combination Therapy in Pakistan

Uncomplicated Falciparum Malaria

Pakistan
Medecins Sans Frontieres, Netherlands
University of Oxford; Mahidol University; Disease Control, Department of Health...

Unknown

Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria (ACT)

Uncomplicated Falciparum Malaria

Myanmar
Aga Khan University

Completed

Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection (QT-Hp)

Treatment of Helicobacter Pylori

Pakistan
University of Giessen

Completed

Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence (3T-AI)

Fecal Incontinence

Germany
Radboud University Medical Center
London School of Hygiene and Tropical Medicine; Kilimanjaro Christian Medical...

Completed

Mass-Drug Administration to Reduce Malaria Transmission (MDATRANS)

Malaria, Falciparum

Tanzania
Abbott

Completed

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients (MONARK)

HIV Infection
Dafra Pharma

Completed

Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria

Plasmodium Falciparum Malaria

Cameroon, Mali, Rwanda, Sudan
Karolinska University Hospital
Muhimbili University of Health and Allied Sciences

Completed

Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers

Uncomplicated Plasmodium Falciparum Malaria

Tanzania
Bristol-Myers Squibb

Completed

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

HIV Infections

United States, Puerto Rico
Menzies School of Health Research
National Health and Medical Research Council, Australia; Wellcome Trust; National...

Completed

A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.

Malaria, Falciparum | Malaria, Vivax

Indonesia
London School of Hygiene and Tropical Medicine
Medical Research Council; National Malaria Control Programme, The Gambia

Completed

Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children

Malaria

Gambia
Gilead Sciences

Completed

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

HIV Infections

United States, Puerto Rico

Search clinical trials for: Triple Artemisinin Combination Therapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations